There are 413 resources available
205P - VERITAC update: phase 2 study of ARV-471, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader in ER+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer
Presenter: Sara Hurvitz
Session: Poster viewing and lunch
206P - Capivasertib (C) + palbociclib (P) and fulvestrant (F) in patients (pts) with HR+/HER2_ advanced breast cancer (ABC): Phase 1b data from CAPItello-292
Presenter: Patrick Neven
Session: Poster viewing and lunch
207P - A doublet metronomic chemotherapeutic regimen with oral vinorelbine and capecitabine (mNC) in patients with metastatic HER2-negative breast cancer: A prospective phase 2 study in China.
Presenter: Yue Chai
Session: Poster viewing and lunch
208P - Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases: a subanalysis of the German Brain metastases in Breast Cancer registry (BMBC)
Presenter: Elena Laakmann
Session: Poster viewing and lunch
209P - Trastuzumab plus lapatinib or chemotherapy in patients with HER2-positive advanced breast cancer refractory to anti-HER2 therapies: a randomized, multicenter, phase II trial (GIM12-TYPHER)
Presenter: Martina Pagliuca
Session: Poster viewing and lunch
210P - Real-world outcomes in patients (pts) with HR+/HER2- metastatic breast cancer (mBC) and germline/tumour BRCA mutations (g/tBRCA1/2m) receiving 1st-line (1L) CDK4/6i plus endocrine therapy (ET)
Presenter: Anton Safonov
Session: Poster viewing and lunch
211P - ER-low breast cancer: evolution from primary tumor to relapse and prognostic impact
Presenter: Federica Miglietta
Session: Poster viewing and lunch
212P - Real world progression-free survival 2 with CDK4/6 inhibitors plus endocrine therapy and subsequent line: results from the multicenter SISTER study
Presenter: Stefania Morganti
Session: Poster viewing and lunch
213P - Real-World Clinical Outcomes Associated with First-Line Palbociclib and Aromatase Inhibitor Therapy Among Patients with HR+/HER2_ Advanced Breast Cancer in Europe
Presenter: Olga Oikonomidou
Session: Poster viewing and lunch
214P - Delphi consensus on the definition of visceral crisis in advanced breast cancer among French Breast Cancer Intergroup Unicancer (UCBG) experts
Presenter: Rébecca Nabeth
Session: Poster viewing and lunch